Aemetis (AMTX) Expected to Announce Earnings on Thursday

Key Points

• Aemetis is expected to report Q4 2025 results before the market opens on Thursday, March 12, 2026, with analysts forecasting EPS of ($0.28) and revenue of $72.07 million and an earnings call at 12:30 PM ET.
• Shares opened at $1.39 (down 0.7%), trading in a 52-week range of $1.22–$3.66, with a market cap around $92 million and a negative PE of -0.86.
• Analysts’ consensus is a Moderate Buy with a $17.00 average price target, and institutional investors own about 27% of the stock after several recent small position changes.

Aemetis (NASDAQ:AMTX - Get Free Report) will likely be posting its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of ($0.28) per share and revenue of $72.07 million for the quarter. Individuals can check the company's upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 12, 2026 at 12:30 PM ET.

Aemetis Trading Down 0.7%

Shares of Aemetis stock opened at $1.39 on Thursday. Aemetis has a 52 week low of $1.22 and a 52 week high of $3.66. The stock has a market cap of $92.02 million, a PE ratio of -0.86 and a beta of 2.61. The company's 50-day moving average price is $1.52 and its two-hundred day moving average price is $1.94.

Institutional Trading of Aemetis

A number of large investors have recently made changes to their positions in the company. Creative Planning bought a new position in Aemetis during the second quarter worth about $30,000. Engineers Gate Manager LP bought a new stake in shares of Aemetis in the second quarter worth about $42,000. Centiva Capital LP acquired a new stake in shares of Aemetis during the third quarter worth about $39,000. Virtu Financial LLC bought a new position in shares of Aemetis during the 4th quarter valued at about $31,000. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Aemetis by 206.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 22,962 shares of the specialty chemicals company's stock valued at $57,000 after purchasing an additional 15,474 shares in the last quarter. Institutional investors own 27.02% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on AMTX shares. Ascendiant Capital Markets dropped their target price on shares of Aemetis from $21.00 to $20.00 and set a "buy" rating on the stock in a report on Wednesday, November 19th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Aemetis in a report on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $17.00.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.